XML 29 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Operating expenses:      
Research and development $ 9,858 $ 9,777 $ 14,428
General and administrative 9,000 8,739 12,383
Restructuring Charges 0 1,019  
Total operating expenses 18,858 19,535 26,811
Loss from operations (18,858) (19,535) (26,811)
Other income (expense)      
Interest income 252 366 282
Interest expense   (1,116) (1,918)
Change in fair value of warrants   29 143
Total other income (expense), net 252 (721) (1,493)
Loss before benefit from income taxes (18,606) (20,256) (28,304)
Benefit from income taxes   477  
Net loss $ (18,606) $ (19,779) $ (28,304)
Net loss per share (basic and diluted) (in dollars per share) $ (0.38) $ (0.58) $ (0.91)
Weighted-average common shares (basic and diluted) (in shares) 49,432,487 34,315,931 30,940,831